At day 14 after infection, the percentage of IFN-γ+ CD4+ T cells is higher in the lungs of mice treated with α-DEC-ESAT than in non α-DEC-ESAT-treated mice (Fig 2A). The gene discussed is IFNG; the disease is infection.